Published in Oncology Business Week, July 3rd, 2005
Further, treatment with Aranesp reduced the need for red blood cell transfusions in cancer patients with chemotherapy-induced anemia. The results of the study were presented at the 41st Annual Meeting of the American Society of Clinical Oncology (ASCO). (Abstract #8129)
"Chemotherapy is most often administered every 3 weeks....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week